XF-73

From Wikipedia, the free encyclopedia

XF-73 is supposedly a breakthrough cure for the hospital superbug MRSA and is being developed by Destiny Pharma Ltd.

^{[1] [2] [3] [4] [5]}

[edit] References

1. ^ Destiny Pharma - XF-73
2. ^ Destiny Pharma - XF series
3. ^ European Society of Clinical Microbiology and Infectious Diseases
4. ^ MRSA: UK scientists 'close to a treatment' - Telegraph
5. ^ Scientists 'on brink of cure' for superbug - Science, News - The Independent